Adamantyl Methoxydiphenyl Propenoic Acid Acne Gel Lecithin Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current acne treatments face challenges in effectively crossing the epidermal layer for localized action and can cause side effects such as skin reddening and dryness, while existing retinoids may not adequately address comedonal formation and inflammation.
Innovation Solution
The use of adamantyl methoxydiphenyl propenoic acid in a pharmaceutical composition, combined with lecithin as a vehicle, for topical application to treat acne, modulating cell differentiation and inflammation, and formulated into a gel for enhanced delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional topical treatments (benzoyl peroxide, retinoids, antibiotics) are applied to treat acne, then acne lesions are targeted, but the epidermal layer blocks drug ingress and side effects (reddening, dryness, allergic reactions) occur
Solution Approach 1:
Lecithin serves as an intermediary substance that facilitates drug delivery through the epidermal layer. The phospholipid structure of lecithin mimics cell membrane composition, enabling it to act as a carrier that transports active principles across the skin barrier while reducing direct irritation from conventional acne treatments
Solution Approach 2:
The invention changes the physical-chemical parameters of the delivery system by using lecithin-based vehicles instead of conventional formulations. This alters the permeability characteristics and biological compatibility of the treatment, enabling better skin penetration with reduced side effects
2Reliability
If lecithin is used as a vehicle to enhance drug delivery through the skin, then pharmacological action is increased, but the complexity of formulation increases
Solution Approach 1:
Lecithin performs multiple functions simultaneously: it acts as an emulsifier, a penetration enhancer, and a skin-conditioning agent. This multi-functionality reduces the need for additional excipients and simplifies the overall formulation despite the enhanced delivery capabilities
3Reliability
If existing retinoids are used to treat acne, then comedonal formation is addressed, but they may not adequately reduce inflammation and can cause skin irritation
Solution Approach 1:
The invention uses composite formulations combining atypical retinoids with lecithin-based delivery systems. This composite approach maintains the comedolytic efficacy of retinoids while the lecithin matrix reduces irritation and improves tolerability through enhanced biocompatibility
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Demonstrates potent comedolytic activity, reducing the number and size of comedones, and atrophying sebaceous glands, with minimal side effects, as shown in rhino mouse models, comparable to existing retinoids like adapalene.
Implementation Method 1
the chemical similarity between lecithin (phosphatidyl choline) and the lipid components of the cell membranes suggests that vehicles based on lecithin can be well tolerated by the body and at the same time increase the pharmacological action
Implementation Method 2
The use of adamantyl methoxydiphenyl propenoic acid in a pharmaceutical composition, combined with lecithin as a vehicle, for topical application to treat acne, modulating cell differentiation and inflammation
Data Source
Figure 1A~1B
AI summary
The use of a substance belonging to the class of atypical retinoids for the topical treatment of acne is described. In particular the effects on an animal model for this skin disease of a pharmaceutical or cosmetic compound for topical use containing adamantyl methoxydiphenyl propenoic acid formulated in a gel are demonstrated.